← Back
$XENE All transactions

Xenon Pharmaceuticals Inc.

M 10b5-1 Plan

$ Value

$192K

Shares

25,000

Price

$8

Filed

Oct 1

Insider

Name

MORTIMER IAN

Title

PRESIDENT, CEO & INTERIM CFO

CIK

0001619961

Roles

Director Officer

Transaction Details

Transaction Date

2025-10-01

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

56,302

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 27, 2024. | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price (rounded to two decimal places), respectively, of shares sold. These share were sold in multiple transactions at prices ranging from $40.00 to $40.495, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. | The shares subject to the option are fully vested and exercisable.

Filing Info

Accession No.

0001193125-25-227202

Form Type

4

Issuer CIK

0001582313

MORTIMER IAN's History

Date Ticker Type Value
2026-01-09 XENE A $0
2026-01-09 XENE A $0
2026-01-02 XENE M $300K
2026-01-02 XENE $1.7M
2026-01-02 XENE $93K
2026-01-02 XENE M $0
2025-12-08 XENE $402K
2025-12-08 XENE $93K
2025-12-05 XENE $647K
2025-11-28 XENE $4K

Other Insiders at XENE (90d)

No other insider activity at this issuer in the last 90 days.